IDCRP is committed to reducing the impact of infectious diseases in the military population through collaborative clinical research
Learn More >>

16 abstracts accepted at 2015 Military Health System Research Symposium, 17-20 August

IDCRP accepted abstracts included: a review of accomplishments within the Trauma Infectious Disease Outcomes Study; expedited development of an Invasive Fungal Infection Clinical Practice Guideline; cost effectiveness analysis of hygiene strategies to prevent methicillin resistant Staphylococcus aureus associated skin and soft tissue infections; and capturing safety and efficacy data of experimental Ebola therapies in the US.

A unique central IRB

The USU Infectious Disease Institutional Review Board (ID IRB), established in 2008 via a Memorandum of Understanding, created a single review pathway for multi-center research and eliminated the need for multiple and repetitive scientific, ethical and second-level review at multiple medical treatment facilities.

Influenza vaccine associated with a reduction in symptom severity among patients with influenza A/H3N2 disease

Findings from an IDCRP study suggest that annual receipt of influenza vaccine, while not 100% effective in preventing disease, may be of some benefit by lessening the severity of symptoms among those who do get influenza. This study was conducted among young, otherwise healthy active duty military personnel and beneficiaries.